NEW YORK, July 25 - Diversa, a San Diego-based microbial genomics firm, announced today that the National Institute of Allergy and Infectious Diseases was prepared to award the company approximately $3.2 million to optimize three antibodies that the U.S. army is already using for the detection of bioterrorism agents.


To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.